Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2022

View Archived Issues

EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance

CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies

Chinese investigators patent new THR-beta agonists

CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo

Gilead Sciences discloses new HIV antivirals

Yonsei University presents new SLC26A4 inhibitors

Chinese researchers identify new anti-claudin18.2 ADCs

New HIF-2alpha PET tracer presented by University of Texas System

PAX8-SOX17 tandem involved in tumor angiogenesis

PKMYT1 targeting useful for the treatment of CCNE1-amplified cancers

Sex disparities of lupus recapitulated in mouse model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...